Moderna (MRNA) Free Cash Flow
Moderna (MRNA) reported free cash flow of $-2.1B in fiscal 2025. Since fiscal 2021 ($13.3B), it has declined 115%. The high over this period was $13.3B, in fiscal 2021.
Free: last 5 years
| Fiscal year | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | ••••• | ••••• | ••••• | ••••• | ••••• | $13.3B | $4.6B | $-3.8B | $-4.1B | $-2.1B |